Showing results (11-20 of 297) with videos related to
Sort By:
Pageof 30
Anti-Cancer Drugs|July 20, 2005
Use of high-throughput arrays for profiling differentially expressed proteins in normal and malignant tissuesGernot Hudelist, Christian F Singer, Ernst Kubista, et al.Breast Care (Basel, Switzerland)|February 20, 2018
Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer PatientsLidia Kowalczyk, Rupert Bartsch, Christian F Singer, et al.Drugs of Today (Barcelona, Spain : 1998)|January 30, 2004
Pharmacological modulation of local feedback mechanisms as a therapeutic approach in breast cancer treatmentChristian F Singer, Gernot Hudelist, Arik Galid, et al.Journal of Personalized Medicine|January 21, 2023
Flexible Risk Evidence Combination Rules in Breast Cancer Precision TherapyMichael Kenn, Rudolf Karch, Christian F Singer, et al.Oncology Letters|January 20, 2017
Cadherin-11 expression is upregulated in invasive human breast cancerKamil Pohlodek, Yen Y Tan, Christian F Singer, et al.Neoplasma|November 4, 2020
Expression of COX-2, p16, and Ki67 in the range from normal breast tissue to breast cancerMichaela Feriancová, Ingrid Walter, Christian F Singer, et al.Reviews in Obstetrics & Gynecology|June 13, 2014
Modern Risk Assessment for Individualizing Treatment Concepts in Early-stage Breast CancerAlex Farr, Rachel Wuerstlein, Annika Heiduschka, et al.Hereditary Cancer in Clinical Practice|May 19, 2025
Translation, cultural adaptation, and pilot testing of the German cancer worry scale among BRCA1/2 pathogenic variant carriers in AustriaAnna-Maria Parger, Daniela Muhr, Christian F Singer, et al.Maturitas|March 27, 2013
Association of BRCA1/2 mutations with FMR1 genotypes: effects on menarcheal and menopausal ageMuy-Kheng M Tea, Andrea Weghofer, Klaus Wagner, et al.Cancer Investigation|July 18, 2023
Neoadjuvant Therapy and Axillary Lymph Node Status in HER2-Positive Breast CancerSabine Danzinger, Christian Pfeifer, Sophia Wimmer, et al.Pageof 30